Search

Search Constraints

You searched for: Author/Creator Barnathan, Elliot S.

Search Results

1. Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials. Issue 19 (7th April 2022)

2. Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study. (19th November 2019)

3. Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With Bronchiectasis. (October 2021)

4. Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older. (17th August 2021)